PROTOONCOGENE EXPRESSION IN DIFFERENTIATING AND NONDIFFERENTIATING CHRONIC MYELOGENOUS LEUKEMIA-CELLS

被引:6
|
作者
WANG, Z
YIN, MY
XIE, XX
YANG, PM
SATO, H
MAYERS, G
RIOBOWAL, C
PREISLER, HD
机构
[1] BARRETT CTR CANC PREVENT TREATMENT & RES,234 GOODMAN ST,CINCINNATI,OH 45267
[2] UNIV CINCINNATI,MED CTR,CINCINNATI,OH 45267
[3] KANTO TEISHIN HOSP,SHINAGAWA KU,TOKYO 141,JAPAN
[4] PK MEM INST,BUFFALO,NY
关键词
D O I
10.1016/0277-5379(90)90119-E
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Despite the profound differences between the chronic and blastic phases of chronic myelogenous leukaemia, no differences between chronic and blastic phase cells have been described at the molecular level. Differences have been found in the levels of expression of c-myc, c-myb and p53, which fell when chronic phase cells were cultured, while the levels of expression of the genes were stable when blastic crisis cells were cultured. In contrast c-fms expression increased and MRS expression decreased after culture of chronic or blastic phase cells. The data suggest that the regulation of expression of some genes in blastic crisis cells is unaltered while that of others is disrupted. It is not known whether the failure of c-myc, c-myb and p53 expression to fall during the culture of blastic phase cells is the cause of or a reflection of the failure of these cells to differentiate. © 1990.
引用
收藏
页码:694 / 698
页数:5
相关论文
共 50 条
  • [1] FC RECEPTOR OF CHRONIC MYELOGENOUS LEUKEMIA-CELLS
    YOSHIDA, H
    KADOTA, A
    SONODA, S
    MURAKAMI, A
    YOSHIDA, N
    KATO, I
    FUKUNISHI, R
    GANN, 1978, 69 (05): : 731 - 732
  • [2] STUDIES OF PROTOONCOGENE EXPRESSION IN THE CHRONIC AND BLASTIC PHASES OF CHRONIC MYELOGENOUS LEUKEMIA
    PREISLER, HD
    AGARWAL, R
    SATO, H
    SINGH, PK
    WANG, ZQ
    SANDBERG, AA
    EUROPEAN JOURNAL OF CANCER, 1990, 26 (09) : 960 - 965
  • [3] BASOPHILIC DIFFERENTIATION OF CHRONIC MYELOGENOUS LEUKEMIA-CELLS INVITRO
    MIYOSHI, I
    UCHIDA, H
    TSUBOTA, T
    KUBONISHI, I
    HIRAKI, S
    KITAJIMA, K
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1977, 19 (04): : 321 - 326
  • [4] HOMOHARRINGTONINE INDUCES APOPTOSIS IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS
    OBRIEN, S
    KEATING, A
    KANTARJIAN, H
    TALPAZ, M
    BERAN, M
    STASS, S
    RIOS, M
    PLUNKETT, W
    BLOOD, 1993, 82 (10) : A555 - A555
  • [5] STRUCTURES OF O-LINKED OLIGOSACCHARIDES ISOLATED FROM NORMAL GRANULOCYTES, CHRONIC MYELOGENOUS LEUKEMIA-CELLS, AND ACUTE MYELOGENOUS LEUKEMIA-CELLS
    FUKUDA, M
    CARLSSON, SR
    KLOCK, JC
    DELL, A
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1986, 261 (27) : 2796 - 2806
  • [6] DIFFERENTIATION AND GROWTH MODULATION OF CHRONIC MYELOGENOUS LEUKEMIA-CELLS BY BRYOSTATIN
    LILLY, M
    TOMPKINS, C
    BROWN, C
    PETTIT, G
    KRAFT, A
    CANCER RESEARCH, 1990, 50 (17) : 5520 - 5525
  • [7] EXPRESSION OF THE MULTIDRUG TRANSPORTER, P-GLYCOPROTEIN, IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS IN BLAST CRISIS
    KUWAZURU, Y
    YOSHIMURA, A
    HANADA, S
    ICHIKAWA, M
    SAITO, T
    UOZUMI, K
    UTSUNOMIYA, A
    ARIMA, T
    AKIYAMA, S
    BRITISH JOURNAL OF HAEMATOLOGY, 1990, 74 (01) : 24 - 29
  • [8] ALKALINE-PHOSPHATASE ACTIVITY IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS IN CULTURES
    CHIYODA, S
    MIURA, Y
    ACTA HAEMATOLOGICA JAPONICA, 1977, 40 (02): : 172 - 176
  • [9] DIFFERENTIAL REGULATION OF JUND BY DIHYDROXYCHOLECALCIFEROL IN HUMAN CHRONIC MYELOGENOUS LEUKEMIA-CELLS
    LASKY, SR
    IWATA, K
    ROSMARIN, AG
    CAPRIO, DG
    MAIZEL, AL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (34) : 19676 - 19679
  • [10] DIFFERENTIATION-ASSOCIATED GANGLIOSIDE CHANGES IN CHRONIC MYELOGENOUS LEUKEMIA-CELLS
    TSUBOYAMA, A
    SAKAMOTO, S
    TAKAKU, F
    ACTA HAEMATOLOGICA JAPONICA, 1985, 48 (06): : 1480 - 1484